Assessment of Physical Functioning and Handling of Spiolto® Respimat® in Patients With Chronic Obstructive Pulmonary Disease (COPD) Requiring Long-acting Dual Bronchodilation in Routine Clinical Practice

CompletedOBSERVATIONAL

Enrollment

1,737

Participants

Timeline

Start Date

January 13, 2016

Primary Completion Date

March 10, 2017

Study Completion Date

April 11, 2017

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Spiolto Respimat

Tiotropium bromide + Olodaterol

Trial Locations (1)

Multiple Locations